Literature DB >> 28922589

Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder.

Francesco Benedetti1,2, Sara Poletti2, Thomas A Hoogenboezem3, Clara Locatelli2, Harm de Wit3, Annemarie J M Wijkhuijs3, Cristina Colombo4, Hemmo A Drexhage3.   

Abstract

BACKGROUND: The clinical relevance of raised levels of circulating cytokines in bipolar disorder is still unclear. Cytokines influence neurotransmitters, neuroplasticity, and white matter integrity. An inconsistent literature suggests that higher cytokine levels could hamper antidepressant response. Total sleep deprivation (TSD) and light therapy (LT) prompt a rapid antidepressant response and can provide a model treatment to study predictors of response.
METHODS: We studied at baseline 15 immune-regulating compounds in 37 consecutively admitted inpatients with a major depressive episode in the course of bipolar disorder (DSM-5 criteria) and in 24 controls. Thirty-one patients (84%) had a lifetime history of drug resistance. Patients were administered 3 TSD + LT cycles in 1 week (study period: 2010-2012). Data were analyzed with age- and false-discovery-rate-corrected analysis of variance and were tested as predictors in a regressive model.
RESULTS: Twenty-three patients (62%) responded to treatment (Inventory of Depressive Symptomatology IDS-C score < 12). Five highly intercorrelated compounds (IL-8, MCP-1, IFN-γ, IL-6, TNF-α) showed higher levels in nonresponder patients as compared to responders, corrected for multiple comparisons (respectively F = 6.138, PFDR = .0134; F = 6.197, PFDR = .0134; F = 4.785, PFDR = .0255; F = 3.782, PFDR = .0441; F = 3.764, PFDR = .0441). A principal component analysis identified a single component that explained 84% of variance of these cytokines (Q² = 0.15), and a high factor score significantly predicted worse response (b = -0.692; W = 4.34, P = .037). A higher body mass index correlated with higher cytokines (r = 0.430, P = .010), indirectly hampering response (b = -0.0192, P = .013).
CONCLUSIONS: Proinflammatory compounds reflecting an M1-like proinflammatory state of monocytes/macrophages are associated with a poor response to antidepressant TSD + LT treatment in bipolar depression. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28922589     DOI: 10.4088/JCP.16m11310

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

Review 1.  Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.

Authors:  Yena Lee; Mehala Subramaniapillai; Elisa Brietzke; Rodrigo B Mansur; Roger C Ho; Samantha J Yim; Roger S McIntyre
Journal:  Ther Adv Psychopharmacol       Date:  2018-11-19

2.  Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein.

Authors:  Daria A Kamaeva; Liudmila P Smirnova; Svetlana N Vasilieva; Daria V Kazantseva; Alisa R Vasilieva; Svetlana A Ivanova
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

3.  High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder.

Authors:  Yun-Rong Lu; Ying-Bo Rao; Yu-Jian Mou; Yan Chen; Han-Fen Lou; Yu Zhang; Dan-Xuan Zhang; Hai-Yan Xie; Li-Wei Hu; Ping Fang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

4.  Depression, GABA, and Age Correlate with Plasma Levels of Inflammatory Markers.

Authors:  Amol K Bhandage; Janet L Cunningham; Zhe Jin; Qiujin Shen; Santiago Bongiovanni; Sergiy V Korol; Mikaela Syk; Masood Kamali-Moghaddam; Lisa Ekselius; Bryndis Birnir
Journal:  Int J Mol Sci       Date:  2019-12-06       Impact factor: 5.923

Review 5.  Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness.

Authors:  Victor Mazereel; Johan Detraux; Davy Vancampfort; Ruud van Winkel; Marc De Hert
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

Review 6.  Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.

Authors:  Kosma Sakrajda; Aleksandra Szczepankiewicz
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

7.  Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus.

Authors:  Dominik K E Beyer; Annika Mattukat; Nadja Freund
Journal:  Int J Bipolar Disord       Date:  2021-03-08

Review 8.  Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.

Authors:  Parisa Ghasemiyeh; Negar Mortazavi; Iman Karimzadeh; Afsaneh Vazin; Laleh Mahmoudi; Ebrahim Moghimi-Sarani; Ashkan MohammadSadeghi; Mina Shahisavandi; Ali Kheradmand; Soliman Mohammadi-Samani
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

9.  Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

Authors:  Mario Gennaro Mazza; Rebecca De Lorenzo; Caterina Conte; Sara Poletti; Benedetta Vai; Irene Bollettini; Elisa Maria Teresa Melloni; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Francesco Benedetti
Journal:  Brain Behav Immun       Date:  2020-07-30       Impact factor: 7.217

Review 10.  Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19.

Authors:  Angel Yun-Kuan Thye; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Priyia Pusparajah; Hooi-Leng Ser; Sivakumar Thurairajasingam; Vengadesh Letchumanan; Learn-Han Lee
Journal:  Biology (Basel)       Date:  2022-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.